Genus (LON:GNS) Shares Pass Above 200-Day Moving Average – Time to Sell?

Shares of Genus plc (LON:GNSGet Free Report) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 1,818.83 ($23.55) and traded as high as GBX 1,970 ($25.50). Genus shares last traded at GBX 1,952 ($25.27), with a volume of 7,896,197 shares.

Analyst Ratings Changes

Separately, Shore Capital restated a “buy” rating on shares of Genus in a report on Wednesday, December 11th.

Get Our Latest Stock Report on Genus

Genus Stock Down 2.7 %

The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.12. The stock has a market cap of £1.24 billion, a P/E ratio of 157.33, a P/E/G ratio of 2.87 and a beta of 0.37. The firm’s fifty day moving average is GBX 1,853.39 and its 200 day moving average is GBX 1,820.50.

Genus (LON:GNSGet Free Report) last released its earnings results on Thursday, February 27th. The company reported GBX 39.80 ($0.52) EPS for the quarter. Genus had a net margin of 1.18% and a return on equity of 1.41%. As a group, equities research analysts forecast that Genus plc will post 70.9644323 EPS for the current year.

Insider Buying and Selling

In other Genus news, insider Jorgen Kokke sold 19,967 shares of Genus stock in a transaction on Friday, February 28th. The shares were sold at an average price of GBX 1,731 ($22.41), for a total transaction of £345,628.77 ($447,473.81). 0.75% of the stock is owned by company insiders.

Genus Company Profile

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Recommended Stories

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.